Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beyond Clinical Correction: Patient-Reported Decision Regret Following Yonsei-Point Botulinum Toxin Type A Injection for Excessive Gingival Display

NCT07874022 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT07874022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07874022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beyond Clinical Correction: Patient-Reported Decision Regret Following Yonsei-Point Botulinum Toxin Type A Injection for Excessive Gingival Display
Lead sponsor
Cairo University
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
February 28, 2027
Enrollment
32 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

excessive gingival display